Pay in 4 interest-free payments of $5.06 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
A phase Ib/II, open-label, multicenter study of INC280 (capmatinib) alone and in combination with buparlisib (BKM120) in adult patients with recurrent glioblastoma
For this, you inject this daily for 7-10 days
Lab-Tested for Purity Ensures consistency for scientific studies
Dlaczego to jest problem
This will lead to a prompt diagnosis so that you do not have prolonged suffering
US$ 26.50
US$ 22.51
US$ 26.32
US$ 20.82
US$ 20.65
US$ 25.31
US$ 24.66
